Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (1)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (2)
- Biology (1)
- Composites (2)
- Computer Science (9)
- Cybersecurity (2)
- Environment (1)
- Fusion (2)
- Isotopes (2)
- Materials Science (5)
- Microscopy (3)
- Nanotechnology (5)
- Neutron Science (5)
- Nuclear Energy (5)
- Physics (7)
- Polymers (1)
- Quantum Science (3)
- Security (5)
- Summit (2)
- Transportation (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.